Caxton Associates (New York)’s Aldeyra Therapeutics ALDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-24,787	Closed	-$246K	–	482
2023 Q1	$246K	Buy	+24,787	New	+$246K	0.04%	378
2022 Q3	–	Sell	-57,860	Closed	-$231K	–	458
2022 Q2	$231K	Buy	+57,860	New	+$231K	0.02%	425